D-Homocystine
CAS: 6027-15-2
Ref. 3D-GAA02715
| 1g | Descontinuado | ||
| 2g | Descontinuado | ||
| 5g | Descontinuado | ||
| 10g | Descontinuado | ||
| 250mg | Descontinuado | ||
| 500mg | Descontinuado |
Informação sobre produto
Nome:
D-Homocystine
Sinónimos:
- Butanoic acid, 4,4′-dithiobis[2-amino-, [R-(R*,R*)]-
- NSC 206271
- (2R,2′R)-4,4′-Dithiobis[2-aminobutanoic acid]
- Butyric acid, 4,4′-dithiobis[2-amino-, D-
- Butanoic acid, 4,4′-dithiobis[2-amino-, (2R,2′R)-
Descrição:
D-homocystine is a human monocyte deaminase inhibitor. It has been shown to inhibit the enzymatic reaction of homocysteine to cystathionine in lung fibroblasts and tissue culture. This inhibition leads to an increase in intracellular levels of homocysteine and subsequently higher concentrations of homocysteine in serum, urine, and cerebrospinal fluid. D-homocystine inhibits chemotaxis of faecalis cells by interfering with the binding between chemoattractant (e.g., fMLP) and receptor molecules on the surface of these cells. It also inhibits trichloroacetic acid-induced DNA methylation in leukemia cells through its ability to interact with divalent metal ions that are essential for methyl transfer reactions.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
268.35 g/mol
Fórmula:
C8H16N2O4S2
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
